$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

A drug-specific nanocarrier design for efficient anticancer therapy 원문보기

Nature communications, v.6, 2015년, pp.7449 - 7449  

Shi, Changying (Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA) ,  Guo, Dandan (Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA) ,  Xiao, Kai (Laboratory of Non-human Primate Disease Model Research, National Chengdu Center for Safety Evaluation of Drugs, State Key Lab of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China) ,  Wang, Xu (Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA) ,  Wang, Lili (Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA) ,  Luo, Juntao (Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA)

Abstract AI-Helper 아이콘AI-Helper

The drug-loading properties of nanocarriers depend on the chemical structures and properties of their building blocks. Here, we customize telodendrimers (linear-dendritic copolymer) to design a nanocarrier with improved in vivo drug delivery characteristics. We do a virtual screen of a library of sm...

참고문헌 (70)

  1. 1 Ferrari M Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 5 161 171 2005 15738981 

  2. 2 Chen ZG Small-molecule delivery by nanoparticles for anticancer therapy Trends Mol Med 16 594 602 2010 20846905 

  3. 3 Hobbs SK Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc Natl Acad Sci U S A 95 4607 4612 1998 9539785 

  4. 4 Maeda H Wu J Sawa T Matsumura Y Hori K Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 271 284 2000 10699287 

  5. 5 Stern ST Translational considerations for cancer nanomedicine J Control Release 146 164 174 2010 20385183 

  6. 6 O’Brien MER Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX ™ /Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Ann Oncol 15 440 449 2004 14998846 

  7. 7 Unezaki S Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy InterJ Pharm 144 11 17 1996 

  8. 8 Gabizon A Shmeeda H Barenholz Y Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies Clin Pharmacokinet 42 419 436 2003 12739982 

  9. 9 Torchilin VP Recent advances with liposomes as pharmaceutical carriers Nature Reviews Drug Discovery 4 145 160 2005 15688077 

  10. 10 Gillies ER Frechet JMJ Dendrimers and dendritic polymers in drug delivery Drug Discovery Today 10 35 43 2005 15676297 

  11. 11 Baker JR Dendrimer-based nanoparticles for cancer therapy ASH Education Program Book 2009 708 719 2009 

  12. 12 Betancourt T Brown B Brannon-Peppas L Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation Nanomedicine (Lond) 2 219 232 2007 17716122 

  13. 13 Du J-Z Du X-J Mao C-Q Wang J Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery J Am Chem Soc 133 17560 17563 2011 21985458 

  14. 14 Duncan R Polymer conjugates as anticancer nanomedicines Nat Rev Cancer 6 688 701 2006 16900224 

  15. 15 Wang F Wang Y-C Dou S Xiong M-H Sun T-M Wang J Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells ACS Nano 5 3679 3692 2011 21462992 

  16. 16 Gaucher G Dufresne MH Sant VP Kang N Maysinger D Leroux JC Block copolymer micelles: preparation, characterization and application in drug delivery J Control Release 109 169 188 2005 16289422 

  17. 17 Mikhail AS Allen C Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphology Biomacromolecules 11 1273 1280 2010 20369884 

  18. 18 Greenwald RB Conover CD Choe YH Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review Crit Rev Ther Drug Carrier Syst 17 101 161 2000 10820646 

  19. 19 Veronese FM PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity Bioconj Chem 16 775 784 2005 

  20. 20 Zheng M Liu X Xu Y Li H Luo C Jiang H Computational methods for drug design and discovery: focus on China Trends Pharmacol Sci 34 549 559 2013 24035675 

  21. 21 Huynh L Neale C Pomes R Allen C Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery Nanomedicine 8 20 36 2012 21669300 

  22. 22 Xiao K A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer Biomaterials 30 6006 6016 2009 19660809 

  23. 23 Luo J Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment Bioconjug Chem 21 1216 1224 2010 20536174 

  24. 24 Xiao K The passive targeting of polymeric micelles in various types and sizes of tumor models Nanoscience and Nanotechnology Letters 2 79 85 2010 

  25. 25 Xiao K Luo J Li Y Lee JS Fung G Lam KS PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma J Control Release 155 272 281 2011 21787818 

  26. 26 Xiao K “OA02” Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo Cancer Res 72 2100 2010 2012 22396491 

  27. 27 Li Y Well-Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic pH Values and cis-Diols Angew Chem Int Ed Engl 51 2864 2869 2012 22253091 

  28. 28 Kato J Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma Mol Pharm 9 1727 1735 2012 22530955 

  29. 29 Huey R Morris GM Olson AJ Goodsell DS A semiempirical free energy force field with charge-based desolvation J Comput Chem 28 1145 1152 2007 17274016 

  30. 30 Fenley AT Henriksen NM Muddana HS Gilson MK Bridging Calorimetry and Simulation through Precise Calculations of Cucurbituril–Guest Binding Enthalpies J Chem Theo Comp 10 4069 4078 2014 

  31. 31 Cong XD Ding MJ Dai DZ Wu Y Zhang Y Dai Y ER stress, p66shc, and p-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats Inflammation 35 1031 1040 2012 22095404 

  32. 32 Huang Q Lu G Shen HM Chung MC Ong CN Anti-cancer properties of anthraquinones from rhubarb Med Res Rev 27 609 630 2007 17022020 

  33. 33 Jiang W Luo J Nangia S Multiscale Approach to Investigate Self-Assembly of Telodendrimer Based Nanocarriers for Anticancer Drug Delivery Langmuir 2015 

  34. 34 Zhang H Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies J Control Release 166 147 158 2013 23266448 

  35. 35 Song A Wang X Zhang J Marik J Lebrilla CB Lam KS Synthesis of hydrophilic and flexible linkers for peptide derivatization in solid phase Bioorg Med Chem Lett 14 161 165 2004 14684320 

  36. 36 Schrödinger Release 2014–1: Maestro v Schrödinger, LLC New York, NY 2014 

  37. 37 Halgren TA Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 J Comput Chem 17 490 519 1996 

  38. 38 Bowers KJ Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters SC 2006 Conference, Proceedings of the ACM/IEEE 2006 

  39. 39 Shan Y Kim ET Eastwood MP Dror RO Seeliger MA Shaw DE How Does a Drug Molecule Find Its Target Binding Site? J Am Chem Soc 133 9181 9183 2011 21545110 

  40. 40 Berendsen HJC Postma JPM van Gunsteren WF Hermans J Interaction Models for Water in Relation to Protein Hydration Intermolecular Forces Pullman B Springer Netherlands 1981 

  41. 41 Berendsen HJC Postma JPM van Gunsteren WF DiNola A Haak JR Molecular dynamics with coupling to an external bath J Chem Phys 81 3684 3690 1984 

  42. 42 Nosé S A unified formulation of the constant temperature molecular dynamics methods J Chem Phys 81 511 519 1984 

  43. 43 Hoover WG Canonical dynamics: Equilibrium phase-space distributions Phys Rev A 1985 

  44. 44 Martyna GJ Tobias DJ Klein ML Constant pressure molecular dynamics algorithms J Chem Phys 101 4177 4189 1994 

  45. 45 Tuckerman M Berne BJ Martyna GJ Reversible multiple time scale molecular dynamics J Chem Phys 97 1990 2001 1992 

  46. 46 Essmann U Perera L Berkowitz ML Darden T Lee H Pedersen LG A smooth particle mesh Ewald method J Chem Phys 103 8577 8593 1995 

  47. 47 Tirado-Rives J Jorgensen WL Molecular dynamics of proteins with the OPLS potential functions. Simulation of the third domain of silver pheasant ovomucoid in water J Am Chem Soc 112 2773 2781 1990 

  48. 48 Banks JL Integrated Modeling Program, Applied Chemical Theory (IMPACT) J Comput Chem 26 1752 1780 2005 16211539 

  49. 49 Fenley AT Henriksen NM Muddana HS Gilson MK Bridging Calorimetry and Simulation through Precise Calculations of Cucurbituril–Guest Binding Enthalpies J Chem Theo Comput 10 4069 4078 2014 

  50. 50 Zhang Y Huo M Zhou J Xie S PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Comput Meth Prog Biomed 99 306 314 2010 

  51. 51 Liu J Xiao Y Allen C Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine J Pharm Sci 93 132 143 2004 14648643 

  52. 52 Huynh L Grant J Leroux JC Delmas P Allen C Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods Pharm Res 25 147 157 2008 17705028 

  53. 53 Faller B Ertl P Computational approaches to determine drug solubility Adv Drug Deliv Rev 59 533 545 2007 17588703 

  54. 54 Pajula K Lehto VP Ketolainen J Korhonen O Computational approach for fast screening of small molecular candidates to inhibit crystallization in amorphous drugs Mol Pharm 9 2844 2855 2012 22867030 

  55. 55 Li C Wang JX Le Y Chen JF Studies of bicalutamide-excipients interaction by combination of molecular docking and molecular dynamics simulation Mol Pharm 10 2362 2369 2013 23646858 

  56. 56 Cui Y Using molecular simulations to probe pharmaceutical materials J Pharm Sci 100 2000 2019 2011 21491434 

  57. 57 Costache AD Sheihet L Zaveri K Knight DD Kohn J Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach Mol Pharm 6 1620 1627 2009 19650665 

  58. 58 Srinivas G Discher DE Klein ML Self-assembly and properties of diblock copolymers by coarse-grain molecular dynamics Nat Mater 3 638 644 2004 15300242 

  59. 59 Kuramochi H Andoh Y Yoshii N Okazaki S All-atom molecular dynamics study of a spherical micelle composed of N-acetylated poly(ethylene glycol)-poly(gamma-benzyl L-glutamate) block copolymers: a potential carrier of drug delivery systems for cancer J Phys Chem B 113 15181 15188 2009 19856949 

  60. 60 Tahir à Guofeng W Ryan M Nicholas B William AG III Molecular modelling of dendrimers for nanoscale applications Nanotechnology 11 77 2000 

  61. 61 Jain V Maingi V Maiti PK Bharatam PV Molecular dynamics simulations of PPI dendrimer-drug complexes Soft Matter 9 6482 6496 2013 

  62. 62 Anderson DG Lynn DM Langer R Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery Angew Chem Int Ed Engl 42 3153 3158 2003 12866105 

  63. 63 Siegwart DJ Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery Proc Natl Acad Sci U S A 108 12996 13001 2011 21784981 

  64. 64 Akinc A A combinatorial library of lipid-like materials for delivery of RNAi therapeutics Nat Biotechnol 26 561 569 2008 18438401 

  65. 65 Lee KS Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Breast Cancer Res Treat 108 241 250 2008 17476588 

  66. 66 Shin HC Alani AW Rao DA Rockich NC Kwon GS Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs J Control Release 140 294 300 2009 19409432 

  67. 67 Li Y Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery Biomaterials 32 6633 6645 2011 21658763 

  68. 68 Shao Y Huang W Shi C Atkinson ST Luo J Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment Ther Deliv 3 1409 1427 2012 23323559 

  69. 69 Juliano R Nanomedicine: is the wave cresting? Nat Rev Drug Discov 12 171 172 2013 23449291 

  70. 70 Bandak S Goren D Horowitz A Tzemach D Gabizon A Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models Anticancer Drugs 10 911 920 1999 10630359 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로